LITHOSUN SR

1. All Details: Specifications
Dosage Form: Uncoated prolonged release tablets.
Storage Conditions: Store at room temperature, protected from light and moisture. Keep out of reach of children.
Batch Number (B.No.): GTF0542A
Manufacturing Date (Mfg. Dt.): 02/2024
Expiry Date (Exp. Dt.): 01/2027
Manufacturing License Number: M.L.: 374/DR/Mfg/2013
Maximum Retail Price (M.R.P.): Rs. 69.00 per 10 tablets (indicated as “M.R.P. Rs. 69.00 (Incl. of all taxes) per 10 Tablets”).
Product Coding Identifiers: PESPF0219 and PF0219
2. General
Brand: LITHOSUN® SR
Generic Name: Lithium Carbonate Prolonged Release Tablets IP
Quantity: 10 Tablets per blister pack (indicated by “per 10 Tablets”).
Type: Allopathic Pharmaceutical / Prescription Drug (indicated by the “Rx” symbol and the red statutory Schedule H prescription caution box).
Form Factor: Blister strip containing solid oral prolonged-release tablets.
Maximum Shelf Life: 2 years and 11 months (from February 2024 to January 2027).
Food Preference / FSSAI: Not Applicable. This is an allopathic, therapeutic prescription drug for clinical neurological and psychiatric treatment, not a commercial food product or dietary supplement. It falls under the regulatory purview of national drug control authorities instead of the FSSAI food authority, and it does not display vegetarian or non-vegetarian food preference icons.
3. Product Details: Ingredients
Each uncoated prolonged release tablet contains:
Lithium Carbonate IP: 400 mg
Excipients: q.s. (Quantity Sufficient)
4. Directions: How to Use
Dosage: As directed by the Physician.
Administration Instructions: Tablet should be swallowed whole and not to be chewed or crushed.
Statutory Warning Label:
SCHEDULE H PRESCRIPTION DRUG – CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.
5. Description
Therapeutic Application: LITHOSUN® SR is an oral psychiatric prescription medication. Its active component, Lithium Carbonate, is a well-established mood stabilizer. The prolonged-release (“SR” or sustained-release) formulation is engineered to dissolve gradually in the gastrointestinal tract, ensuring a steady release of the active drug into the bloodstream over an extended period. This mechanism helps maintain stable therapeutic plasma concentrations and reduces the peak-dose side effects often associated with immediate-release variants. It is standardly prescribed under rigorous medical supervision to manage manic episodes and prevent recurrence in bipolar disorder.
Visual Presentation: The product is packed in a protective silver aluminum blister strip designed to insulate the individual tablets from light and moisture. The foil layout features a prominent repeating blue text design for the brand name, bold black typography for manufacturing tracking parameters, a distinct red warning band for safety, and the official corporate marker for Sun Pharma Laboratories.
6. Manufacturer Information
Manufactured in India by: sun pharma laboratories ltd.
Factory Address: Vill. Kokjhar, Mirza Palashbari Road, P.O.: Palashbari, Dist.: Kamrup, Assam-781 128.
7. Marketed By
Marketed by: sun pharma laboratories ltd.